metastatic colorectal cancer: optimizing dosing strategy for late-line therapies
Published 6 years ago • 533 plays • Length 28:29Download video MP4
Download video MP3
Similar videos
-
35:27
expert perspectives: optimizing late-line therapy for patients with metastatic colorectal cancer
-
11:00
overview of late-line therapies for metastatic colorectal cancer
-
8:32
dose optimization for improved outcomes in refractory mcrc
-
13:18
debate 1: first-line treatment of metastatic colorectal cancer - calgb 80405
-
18:55
emerging treatment options for mcrc patients in the late-line setting
-
9:54
late treatment lines in colorectal cancer: any progress?
-
8:05
debate: is there an optimal sequence for first-line therapy in mcrc? - no
-
15:55
enhancing outcomes in metastatic colorectal cancer with angiogenesis inhibitors
-
15:12
initial management of metastatic crc in 2019
-
34:51
personalizing and optimizing patient care in metastatic colorectal cancer
-
8:47
colorectal cancer: dosing strategies with regorafenib
-
15:00
controversy debate 4: treatment algorithms in metastatic crc - nccn guidelines
-
36:11
first-line drug therapy selection strategy for metastatic colorectal cancer treatment
-
0:56
how to prevent colon cancer (the short version)
-
20:02
optimizing strategies for the treatment of colorectal cancer in the biomarker era
-
9:42
selecting and optimizing treatment strategies in patients with metastatic colorectal cancer
-
1:09:49
emerging approaches in first-line therapy for metastatic colorectal cancer
-
10:30
debate 1: first-line treatment of metastatic colorectal cancer - fire-3
-
9:12
debate: is there an optimal treatment for refractory colorectal cancer? - immunotherapy